0000899243-15-002466.txt : 20150805
0000899243-15-002466.hdr.sgml : 20150805
20150805183216
ACCESSION NUMBER: 0000899243-15-002466
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150805
FILED AS OF DATE: 20150805
DATE AS OF CHANGE: 20150805
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aimmune Therapeutics, Inc.
CENTRAL INDEX KEY: 0001631650
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 452748244
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 8000 MARINA BOULEVARD
STREET 2: SUITE 300
CITY: BRISBANE
STATE: CA
ZIP: 94005-1884
BUSINESS PHONE: (650) 614-5220
MAIL ADDRESS:
STREET 1: 8000 MARINA BOULEVARD
STREET 2: SUITE 300
CITY: BRISBANE
STATE: CA
ZIP: 94005-1884
FORMER COMPANY:
FORMER CONFORMED NAME: Allergen Research Corp
DATE OF NAME CHANGE: 20150123
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ENRIGHT PATRICK G
CENTRAL INDEX KEY: 0001253886
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37519
FILM NUMBER: 151030458
MAIL ADDRESS:
STREET 1: CO LONGITUDE CAPITAL PARTNERS LLC
STREET 2: 800 EL CAMINO REAL, SUITE 220
CITY: MENLO PARK
STATE: CA
ZIP: 94025
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Tammenoms Bakker Juliet
CENTRAL INDEX KEY: 0001431159
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37519
FILM NUMBER: 151030460
MAIL ADDRESS:
STREET 1: LONGITUDE CAPITAL MANAGEMENT CO., LLC
STREET 2: 800 EL CAMINO REAL, SUITE 220
CITY: MENLO PARK
STATE: CA
ZIP: 94025
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Longitude Venture Partners II, L.P.
CENTRAL INDEX KEY: 0001527510
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37519
FILM NUMBER: 151030459
BUSINESS ADDRESS:
STREET 1: 800 EL CAMINO REAL, SUITE 220
CITY: MENLO PARK
STATE: CA
ZIP: 94025
BUSINESS PHONE: 650-854-5700
MAIL ADDRESS:
STREET 1: 800 EL CAMINO REAL, SUITE 220
CITY: MENLO PARK
STATE: CA
ZIP: 94025
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Longitude Capital Partners II, LLC
CENTRAL INDEX KEY: 0001647491
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37519
FILM NUMBER: 151030461
BUSINESS ADDRESS:
STREET 1: 800 EL CAMINO REAL
STREET 2: SUITE 220
CITY: MENLO PARK
STATE: CA
ZIP: 94025
BUSINESS PHONE: 650-854-5700
MAIL ADDRESS:
STREET 1: 800 EL CAMINO REAL
STREET 2: SUITE 220
CITY: MENLO PARK
STATE: CA
ZIP: 94025
3
1
doc3.xml
FORM 3 SUBMISSION
X0206
3
2015-08-05
0
0001631650
Aimmune Therapeutics, Inc.
AIMT
0001647491
Longitude Capital Partners II, LLC
800 EL CAMINO REAL
SUITE 220
MENLO PARK
CA
94025
0
0
1
0
0001431159
Tammenoms Bakker Juliet
C/O LONGITUDE CAPITAL PARTNERS II, LLC
800 EL CAMINO REAL, SUITE 220
MENLO PARK
94025
0
0
1
0
0001527510
Longitude Venture Partners II, L.P.
800 EL CAMINO REAL
SUITE 220
MENLO PARK
CA
94025
0
0
1
0
0001253886
ENRIGHT PATRICK G
C/O LONGITUDE CAPITAL PARTNERS II, LLC
800 EL CAMIO REAL, SUITE 220
MENLO PARK
CA
94025
1
0
1
0
Series A Convertible Preferred Stock
0.00
Common Stock
3873530
I
By: Longitude Venture
Partners II, L.P.
Series B Convertible Preferred Stock
0.00
Common Stock
3248600
I
By: Longitude Venture
Partners II, L.P.
The Series A Convertible Preferred Stock and Series B Convertible Preferred Stock automatically convert into shares of Issuer's Common Stock on a 1:1 basis immediately prior to the completion of Issuer's initial public offering.
The expiration date is not relevant to the conversion of these securities.
This report is filed jointly by Longitude Capital Partners II, LLC ("Longitude Capital II"), Longitude Venture Partners II, L.P. ("Longitude Venture II"), Patrick G. Enright ("Mr. Enright") and Juliett Tammenoms Bakker ("Ms. Bakker"), all of whom share beneficial ownership of more than 10% of the capital stock of the Issuer. Longitude Capital II as general partner of Longitude Venture II maybe deemed to have sole voting, investment and dispositive power over the shares held by Longitude Venture II. Mr. Enright and Ms. Bakker are each managing members of Longitude Capital II and in their capacity as such, may be deemed to exercise shared voting and investment power over the shares held by Reporting Persons. Each of Longitude Capital II, Mr. Enright and Ms. Bakker disclaims beneficial ownership of such shares except to the extent of its, his or her pecuniary interest therein.
LONGITUDE CAPITAL PARTNERS II, LLC, a Delaware limited liability company, By: /s/ Patrick G. Enright, Managing Member
2015-08-05
LONGITUDE VENTURE PARTNERS II, L.P., By: Longitude Capital Partners II, LLC, a Delaware limited liability company, Its General Partner, By: /s/ Patrick G. Enright, Managing Member
2015-08-05
/s/ Patrick G. Enright
2015-08-05
/s/ Juliett Tammenoms Bakker
2015-08-05